Search Results

Expression levels of CXC chemokine receptors 3 are associated with clinical phenotype of type 1 diabetes.

• Authors : Yamada S; Department of Internal Medicine, Kitasato Institute Hospital, 5-9-1 Shirokane, Minato-ku, Tokyo 108-8642, Japan. ; Oikawa Y

Subjects: Phenotype*; Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/Diabetes Mellitus, Type 1/*immunology ; Receptors, Chemokine/Receptors, Chemokine/Receptors, Chemokine/*immunology

• Source: Annals of the New York Academy of Sciences [Ann N Y Acad Sci] 2006 Oct; Vol. 1079, pp. 186-9.Publisher: New York Academy of Sciences Country of Publication: United States NLM ID: 7506858 Publication Model: Print Cited Medium: Print ISSN:

Record details

Single nucleotide polymorphisms in the coding regions of human CXC-chemokine receptors CXCR1, CXCR2 and CXCR3.

• Authors : Kato H; Department of Human Genetics, Graduate School of Medicine, University of Tokyo, Japan.; Tsuchiya N

Subjects: Polymorphism, Single Nucleotide*; Receptors, Chemokine/Receptors, Chemokine/Receptors, Chemokine/*genetics ; Receptors, Interleukin-8A/Receptors, Interleukin-8A/Receptors, Interleukin-8A/*genetics

• Source: Genes and immunity [Genes Immun] 2000 Jun; Vol. 1 (5), pp. 330-7.Publisher: Nature Pub. Group Country of Publication: England NLM ID: 100953417 Publication Model: Print Cited Medium: Print ISSN: 1466-4879

Record details

Safety and effectiveness of mogamulizumab in relapsed or refractory CC chemokine receptor 4‐positive peripheral T‐cell lymphoma and relapsed or refractory cutaneous T‐cell lymphoma: A post‐marketing surveillance in Japan.

• Authors : Ishitsuka, Kenji; Yasukawa, Tomoharu; Tsuji, Yukie

Subjects: CUTANEOUS T-cell lymphoma; T-cell lymphoma; CHEMOKINE receptorsJAPAN

• Source: Hematological Oncology; Jul2024, Vol. 42 Issue 4, p1-11, 11p

Record details

Effects of let-7a microRNA and C-C chemokine receptor type 7 expression on cellular function and prognosis in esophageal squamous cell carcinoma.

• Authors : Yura, Masahiro; Fukuda, Kazumasa; Matsuda, Satoru

• Source: BMC Cancer. October 15, 2022, Vol. 22 Issue 1.

Record details

Safety and effectiveness of mogamulizumab in relapsed or refractory adult T‐cell leukemia‐lymphoma.

• Authors : Ishitsuka, Kenji; Yurimoto, Satoshi; Tsuji, Yukie

Subjects: DRUG side effects; INTRAVENOUS therapy; CHEMOKINE receptorsJAPAN

• Source: European Journal of Haematology; May2019, Vol. 102 Issue 5, p407-415, 9p

Record details

CXCR2 signaling might have a tumor-suppressive role in patients with cholangiocarcinoma.

• Authors : Yamamoto, Yurie; Sugimoto, Atsushi; Maruo, Koji

• Source: PLoS ONE. April 4, 2022, Vol. 17 Issue 4, e0266027.

Record details

Researcher from Kyushu University Publishes New Studies and Findings in the Area of Cancer (Identification of effective CCR2 inhibitors for cancer therapy using humanized mice).

Subjects: CHEMOKINE receptors; RESEARCH personnel; MYELOID-derived suppressor cellsJAPAN

• Source: Drug Week; 12/01/2023, p982-982, 1p

Record details

HTLV-1 induces a Th1-like state in [CD4.sup.+] [CCR4.sup.+] T cells.

• Authors : Araya, Natsumi; Sato, Tomoo; Ando, Hitoshi

• Source: Journal of Clinical Investigation. August 1, 2014, Vol. 124 Issue 8, p3431, 12 p.

Record details

miRNA-mediated deadenylation is orchestrated by GW182 through two conserved motifs that interact with CCR4-NOT.

• Authors : Fabian, Marc R.; Cieplak, Maja K.; Frank, Filipp

• Source: Nature Structural and Molecular Biology. November 1, 2011, Vol. 18 Issue 11, p1211, 8 p.

Record details

Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma.

• Authors : Ijichi, Hideaki; Chytil, Anna; Gorska, Agnieszka E.

• Source: Journal of Clinical Investigation. October 1, 2011, Vol. 121 Issue 10, p4106, 12 p.

Record details